Advanced search×

Familial Moyamoya disease in two European children.

J Child Neurol 22(12):1371-6 (2007) PMID 18174554

We present familial Moyamoya disease in two European children and emphasize the importance of familial factors in the pathogenesis of this disease and its appearance not only in Asians but in the Western population as well. The first patient, a Greek female infant, also has coagulation disorders. Her mother, also suffering from Moyamoya and other family members, have similar coagulation disorders (Factor V Leiden, Methylene-tetrahydrofolic reductase and Factor II 20210A mutations). The second patient, a Scottish boy, is unique in that familial Moyamoya affects five members of three consecutive generations of his maternal family. Genetic analysis in the Greek family demonstrated no abnormality on chromosome 3p26, as in other cases. However, the mitochondrial DNA and Y chromosomal genotype showed that affected members had the same sequence of the Mitochondrial 3 portion of D-loop with Japanese patients. These findings suggest that the pathogenesis of Moyamoya may vary across races and ethnic groups.

DOI: 10.1177/0883073807307101
Version: za2963e q8za6 q8zba q8zce q8zd2 q8ze1 q8zff q8zg8

Similar articles you may find interesting…

  1. Small Intestinal Bacterial Overgrowth and Orocecal Transit Time in Patients of Inflammatory Bowel Disease.

    Dig Dis Sci (2013) PMID 23649377

    Mean ± standard deviation (SD) of OCTT in patients of IBD was significantly higher as compared to controls. Furthermore, OCTT was significantly higher in CD patients as compared to UC patients. It was also observed that occurrence of SIBO was significantly higher in IBD patients as compared to co...
  2. Quantifying Options for Reducing Coronary Heart Disease Mortality By 2020.

    Circulation (2013) PMID 23661723

    Two contrasting scenarios of change in CVH metrics could prevent 24-30% of the CHD deaths expected in 2020, though with differing impacts by age. Unfavorable continuing trends in obesity and diabetes would have substantial adverse effects. This analysis demonstrates the utility of modelling to infor...
  3. The Comprehensive Antibiotic Resistance Database.

    Antimicrob Agents Chemother (2013) PMID 23650175

    We have initiated development of such tools in the form of the Comprehensive Antibiotic Research Database (CARD, arpcard.mcmaster.ca). The CARD integrates disparate molecular and sequence data, provides a unique organizing principle in the form of the Antibiotic Resistance Ontology (ARO), and can qu...